Expression of IFN-γ-inducible chemokines in inclusion body myositis

被引:60
作者
Raju, R [1 ]
Vasconcelos, O [1 ]
Granger, R [1 ]
Dalakas, MC [1 ]
机构
[1] NINDS, Neuromuscular Dis Sect, NIH, Bethesda, MD 20892 USA
关键词
Mig; IP-10; CXCR3; myotube; inclusion body myositis; chemokines;
D O I
10.1016/S0165-5728(03)00218-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Because IFN-gamma-inducible chemokines, Mig (CXCL9), IP-10 (CXCL10), I-TAC (CXCL11) and their receptor, CXCR3, are critical molecules in T cell trafficking and generation of effector T cells, we examined their expression in the muscle biopsies of patients with sporadic inclusion body myositis (s-IBM) and disease controls. The functional role of these molecules was also studied by examining the effect and time kinetics of IFN-gamma in inducing Mig and IP-10 expression in human myotubes in vitro. We found significantly high levels of Mig and IP-10 mRNA expression in s-IBM muscles compared to controls. IFN-gamma upregulated the mRNA expression of Mig and IP-10 by human myotubes in a dose-dependent manner. By double-label immunohistochemistry, Mig was expressed on a subset of CD8(+) cells and the areas of the muscle fiber in contact or contiguous to the T cells; CXCR3 was expressed only on a subset of the autoinvasive CD8(+) T cells but not the myofibers. IP-10 and I-TAC were not detected by immunocytochemistry. The findings indicate that in s-IBM, IFN-gamma is involved in the upregulation and in situ production of proinflammatory chemokines, which, in turn, participate in the recruitment of activated T cells and contribute to the self-sustaining nature of endomysial inflammation. Crown Copyright (C) 2003 Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:125 / 131
页数:7
相关论文
共 37 条
[1]   MONOCLONAL-ANTIBODY ANALYSIS OF MONONUCLEAR-CELLS IN MYOPATHIES .1. QUANTITATION OF SUBSETS ACCORDING TO DIAGNOSIS AND SITES OF ACCUMULATION AND DEMONSTRATION AND COUNTS OF MUSCLE-FIBERS INVADED BY T-CELLS [J].
ARAHATA, K ;
ENGEL, AG .
ANNALS OF NEUROLOGY, 1984, 16 (02) :193-208
[2]  
Askanas Valerie, 1995, Current Opinion in Rheumatology, V7, P486, DOI 10.1097/00002281-199511000-00005
[3]  
Bartoli C, 2001, ACTA NEUROPATHOL, V102, P385
[4]  
Behrens L, 1998, J IMMUNOL, V161, P5943
[5]   Chemokines in tissue-specific and microenvironment-specific lymphocyte homing [J].
Campbell, JJ ;
Butcher, EC .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (03) :336-341
[6]   Expression of matrix metalloproteinases in the muscle of patients with inflammatory myopathies [J].
Choi, YC ;
Dalakas, MC .
NEUROLOGY, 2000, 54 (01) :65-71
[7]   Increased expression of β-chemokines in muscle of patients with inflammatory myopathies [J].
Confalonieri, P ;
Bernasconi, P ;
Megna, P ;
Galbiati, S ;
Cornelio, F ;
Mantegazza, R .
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (02) :164-169
[8]   Molecular immunology and genetics of inflammatory muscle diseases [J].
Dalakas, MC .
ARCHIVES OF NEUROLOGY, 1998, 55 (12) :1509-1512
[9]  
Dalakas MC, 2002, REV NEUROL-FRANCE, V158, P948
[10]   POLYMYOSITIS, DERMATOMYOSITIS, AND INCLUSION-BODY MYOSITIS [J].
DALAKAS, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1487-1498